48 min ago | BioSpace
FDA Approves Bristol-Myers Squibb Company , Otsuka Pharmaceutical...
PRINCETON, N.J. & TOKYO-- --Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd.
Wall Street Breakfast: Must-Know News
JPMorgan, Cazenove to tie the knot. Sources say JPMorgan is set to pay close to 1B for the 50% it doesn't already own in Cazenove, the vaunted 190-year U.K. stock broker.
FDA OKs Abilify for autism-linked irritability
The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co.
U.S. Food and Drug Administration Approves ABILIFY (aripiprazole) for ...
U.S. Food and Drug Administration Approves ABILIFYA for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients Submitted by admin on 11/20/2009 @ 5:50 PM Companies mentioned in this article: Bristol-Myers Squibb Company & Otsuka Pharmaceutical Co., Ltd.
The Bristol Blotter: Nov. 20, 2009
Bristol Virginia Police Department - Animal Control is seeking help in tracking down a tiny black dog that escaped from its owner at the Old Airport Road Bojangles near Exit 7 of Interstate 81.
CNNa s Oa Brien details 22-year career during Bristol stop
Emmy Award-winning television journalist Soledad O'Brien had a lighthearted, yet productive Saturday morning.
Heartburn Drugs Can Thwart Popular Blood Thinner
Combining the antacid Prilosec with the popular blood thinner Plavix can cut the effectiveness of Plavix by half, putting patients at risk for heart attack or stroke, U.S. health officials said Tuesday.
This Poison Pill Aids Investors
Poison pills, or provisions to thwart takeovers, usually benefit management rather than shareholders.
Cracking down on corporate pill-pushers
Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again.
Pharmaceutical giant Bristol-Myers Squibb to invest 3.5million in its Moreton base
PHARMACEUTICAL giant Bristol-Myers Squibb is investing 3.5million in its Moreton base.
FDA warns that heartburn drug Prilosec can block benefits of blood thinner Plavix
Federal health officials said Tuesday a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
Wall Street jumps as retail sales rebound
President and CEO Fritz Henderson speaks during a news conference at company headquarters in Detroit, Monday, Nov.
Mon Nov 16, 2009 5:59am EST - U.S. flags hang on the facade of the New York Stock Exchange, October 8, 2009.
Aspirin Without Plavix as Good After Heart Bypass
Aspirin alone proved as effective as aspirin plus the blood clot preventer Plavix in keeping coronary artery bypass grafts open during the first year after surgery, according to a study released on Monday.
Bristol-Myers splits off Mead Johnson Nutrition
Bristol-Myers Squibb is splitting off its holdings in infant formula maker Mead Johnson Nutrition in order to focus on its biopharmaceutical business.
RENO a ' A medical helicopter crashed early Saturday north of Reno near the Nevada-California state line, killing three crew members aboard, officials said.
Palin says she didn't know Bristol was having sex
In this photo released by ABC, Barbara Walters is seen during an interview with fromer Alaska Governor and Republican Vice-Presidential candidate Sarah Palin, and her daughters Piper, center left, and Willow Palin, at a New York City hotel, Friday, Nov.
Palin book goes after McCain camp but not Levi
Sarah Palin's new book, "Going Rogue: An American Life." In "Going Rogue," which will be released Tuesday, Palin also laments about everyone in her entourage being forced to wear fancy clothes she couldn't afford -- preferring simpler, cheaper garb.
ImmunoGen Chairman Mitchel Sayare steps down
Biotechnology company ImmunoGen Inc. said Wednesday that Stephen McCluski is replacing Mitchel Sayare as chairman of the board.
Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences
Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Human Genome Sciences .
Also on Topix